Aclaris Therapeutics Inc - Real-time stock metrics, market data, and comprehensive analysis
Fetching stock data...
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.
No news available
Limited Time
Get premium stock ratings, research, analyst insights, and portfolio tools with a limited-time discount.
25% off Seeking Alpha Premium through July 7.
Claim 25% discountSponsored partner offer: The 25% Seeking Alpha Premium discount is available for a limited time. Terms apply.